Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.0700
0.00 (0.00%)
Jan 20, 2026, 12:59 PM EST
Lobe Sciences Company Description
Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases.
It offers Altemia® MF, a medical food designed to manage deficiencies in sickle cel disease. Lobe Sciences Ltd. was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020.
The company was founded in 2018 and is headquartered in Vancouver, Canada.
Lobe Sciences Ltd.
| Country | Canada |
| Founded | 2018 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Frederick Sancilio |
Contact Details
Address: 1771 Robson Street Vancouver, BC V6G 3B7 Canada | |
| Phone | 949-505-5623 |
| Website | lobesciences.com |
Stock Details
| Ticker Symbol | LOBE |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | September - August |
| Reporting Currency | CAD |
| ISIN Number | CA53946V2066 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Herman Williams M.B.A., M.D., M.P.H. | Chief Executive Officer Alt, Inc |
| Dr. Frederick Dominick Sancilio M.S., Ph.D. | Chairman and Chief Executive Officer |
| Charles F. Goulburn M.B.A. | President |
| Yong Yao | Executive Vice President and Chief Financial Officer |
| Maghsoud Dariani B.S., M.S. | Chief Science Officer |